Crcm - Centre De Recherche En Cancérologie De Marseille company information, Employees & Contact Information

Nelson Dusetti Announces the 1st CRCM Symposium on Translational Oncology Oncodaily

CRCM Symposium 2026 Oncodaily

Establishment of a mouse hepatocellular carcinoma tumoroid panel recapitulating inter- and intra- heterogeneity for disease modelling and combinatorial drug discovery Cell Communication and Signaling

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active Nature

Nelson Dusetti: CRCM is looking for a postdoctoral researcher Oncodaily

Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study Nature

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms The Lancet

Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression EMBO Press

Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia Frontiers

Improving AutoDock Vina Using Random Forest: The Growing Accuracy of Binding Affinity Prediction by the Effective Exploitation of Larger Data Sets Wiley Online Library

Journal of Contemporary Brachytherapy Termedia

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer Dove Medical Press

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation Clinical Epigenetics

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells Nature

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication Nature

Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA Nature